Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001558370-22-010281
Filing Date
2022-06-24
Accepted
2022-06-24 17:10:54
Documents
7
Effectiveness Date
2022-06-24

Document Format Files

Seq Description Document Type Size
1 S-8 tmb-20220621xs8.htm S-8 104619
2 EX-5.1 tmb-20220621xex5d1.htm EX-5.1 17636
3 EX-23.2 tmb-20220621xex23d2.htm EX-23.2 4105
4 EX-FILING FEES tmb-20220621xexfilingfees.htm EX-FILING FEES 18445
5 GRAPHIC tmb-20220621xex5d1001.jpg GRAPHIC 4911
6 GRAPHIC tmb-20220621xex23d2002.jpg GRAPHIC 6152
7 GRAPHIC tmb-20220621xex23d2001.jpg GRAPHIC 3071
  Complete submission text file 0001558370-22-010281.txt   166063
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-265838 | Film No.: 221040883
SIC: 2834 Pharmaceutical Preparations